Centrus Surges on Strong LEU Sales, Eyes Domestic Nuclear Fuel Boom

Ticker: LEU · Form: 10-Q · Filed: Nov 6, 2025 · CIK: 1065059

Centrus Energy CORP 10-Q Filing Summary
FieldDetail
CompanyCentrus Energy CORP (LEU)
Form Type10-Q
Filed DateNov 6, 2025
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.10, $115.0 million, $1.00
Sentimentbullish

Sentiment: bullish

Topics: Nuclear Energy, Uranium Enrichment, HALEU, Government Contracts, Energy Security, Geopolitics, Supply Chain

Related Tickers: LEU, XLE, URA, CCJ, UEC

TL;DR

**LEU is a buy; geopolitical tailwinds and DOE contracts are setting up a domestic nuclear fuel powerhouse.**

AI Summary

Centrus Energy Corp. (LEU) reported a significant increase in revenue for the three months ended September 30, 2025, reaching $105.2 million, up from $78.9 million in the prior year, primarily driven by higher sales in its LEU segment. Net income for the quarter also saw a substantial rise to $15.8 million, or $0.90 per diluted share, compared to $10.1 million, or $0.58 per diluted share, in the same period of 2024. The company's strategic outlook is heavily influenced by new Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded by the DOE in late 2024 for HALEU production, LEU production, and HALEU deconversion, signaling a push for domestic nuclear fuel independence. Key business changes include the redemption of 8.25% Notes in March 2025, reducing interest expense. However, the company faces considerable risks related to geopolitical conflicts, specifically the Import Ban Act and Russian Decree impacting Russian LEU imports, and its dependence on government funding and task orders for its HALEU and LEU production expansion initiatives. The company's ability to secure additional U.S. government waivers from the Import Ban Act is critical for its TENEX Supply Contract.

Why It Matters

Centrus's performance is critical for investors as it navigates a volatile global energy market, particularly with the U.S. pushing for domestic nuclear fuel independence. The company's success in HALEU and LEU production directly impacts the future of advanced nuclear reactors and energy security, offering a competitive alternative to Russian supply. For employees, these new DOE contracts signify job stability and growth in Piketon, Ohio, and Oak Ridge, Tennessee. Customers, primarily utilities, benefit from a more secure and diversified fuel supply chain, reducing reliance on geopolitical adversaries. The broader market sees Centrus as a bellwether for the nascent U.S. nuclear renaissance, with its ability to scale production influencing the viability of next-generation nuclear power.

Risk Assessment

Risk Level: medium — The risk level is medium due to significant reliance on government contracts and the volatile geopolitical landscape. While new DOE IDIQ contracts for HALEU and LEU production offer substantial opportunity, the company explicitly states risks related to 'DOE not issuing any major task orders' or 'not providing adequate share of the appropriated funding.' Furthermore, the 'Import Ban Act' and 'Russian Decree' create uncertainty around the TENEX Supply Contract, with Centrus needing 'additional U.S. government waivers' to continue importing Russian LEU, directly impacting its supply chain.

Analyst Insight

Investors should closely monitor Centrus's progress on securing task orders under its new DOE IDIQ contracts and any developments regarding waivers for Russian LEU imports. Given the strategic importance of domestic nuclear fuel, consider LEU as a long-term play, but be aware of potential short-term volatility tied to government funding decisions and geopolitical events.

Financial Highlights

revenue
$105.2M
net Income
$15.8M
eps
$0.90
revenue Growth
+33.3%

Revenue Breakdown

SegmentRevenueGrowth
LEU$105.2M+33.3%

Key Numbers

Key Players & Entities

FAQ

What were Centrus Energy Corp.'s key financial results for the quarter ended September 30, 2025?

Centrus Energy Corp. reported revenue of $105.2 million for the three months ended September 30, 2025, a significant increase from $78.9 million in the same period of 2024. Net income for the quarter was $15.8 million, or $0.90 per diluted share, up from $10.1 million, or $0.58 per diluted share, in the prior year.

How do recent geopolitical events, like the Import Ban Act, affect Centrus Energy's operations?

The 'Prohibiting Russian Uranium Imports Act' (Import Ban Act), effective August 11, 2024, bans imports of LEU from Russia into the U.S. This directly impacts Centrus's TENEX Supply Contract, requiring the company to secure additional U.S. government waivers to continue importing Russian LEU, posing a significant supply chain risk.

What is Centrus Energy's strategic outlook regarding domestic nuclear fuel production?

Centrus's strategic outlook is focused on expanding domestic nuclear fuel production, particularly High Assay Low-Enriched Uranium (HALEU) and Low-Enriched Uranium (LEU). This is evidenced by the Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded by the DOE in late 2024 for HALEU production, LEU production, and HALEU deconversion, aiming to reduce reliance on foreign sources.

What are the primary risks associated with Centrus Energy's government contracts?

Primary risks include the DOE not issuing major task orders under the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract, or not providing adequate appropriated funding. There's also a risk that Centrus may not win additional task orders to expand the American Centrifuge plant's capacity.

How has Centrus Energy managed its debt obligations recently?

Centrus Energy redeemed its 8.25% Notes, originally maturing in February 2027, in March 2025. The company still has 0% Convertible Senior Notes maturing in August 2032 and 2.25% Convertible Senior Notes maturing in November 2030 as long-term liabilities.

What is HALEU and why is it important for Centrus Energy?

HALEU (High Assay Low-Enriched Uranium) is a crucial fuel for advanced nuclear reactors. It is important for Centrus because the company has a three-year, $115.0 million cost-share HALEU Demonstration Contract with the DOE and was awarded an IDIQ HALEU Production Contract in October 2024, positioning it as a key domestic supplier.

What impact does the Russian Decree have on Centrus Energy's supply chain?

The Russian Federal Decree No. 1544, passed on November 14, 2024, rescinded TENEX's general license to export LEU to the United States through December 31, 2025. This creates a risk that TENEX may be unable or unwilling to deliver LEU under the TENEX Supply Contract, potentially disrupting Centrus's supply.

What are Centrus Energy's plans for expanding its enrichment capacity?

Centrus plans to expand its enrichment capacity for both HALEU and LEU, primarily at its Piketon, Ohio facility. This expansion is contingent on winning additional task orders under the HALEU Production Contract and LEU Production Contract, and securing financing to make the expansion commercially viable.

Who are Centrus Energy's major customers and suppliers?

Centrus's revenue is largely dependent on its largest customers, though specific names are not disclosed in this section. Key suppliers include TENEX under the TENEX Supply Contract and Orano under the Orano Supply Agreement, providing LEU and SWU components.

What are the risks related to Centrus Energy's ability to attract and retain employees?

Centrus faces risks related to its inability to attract qualified employees necessary for the planned expansion of its operations in Oak Ridge, Tennessee, or Piketon, Ohio. This could hinder its ability to meet contractual obligations and scale production for HALEU and LEU.

Risk Factors

Industry Context

The nuclear fuel industry is undergoing a resurgence driven by global decarbonization efforts and a renewed focus on energy security. Centrus operates in a critical niche, providing LEU and developing capabilities for HALEU, essential for both existing and next-generation nuclear reactors. The competitive landscape is influenced by geopolitical factors, particularly concerning Russian supply, and a strong push for domestic production capabilities in the U.S.

Regulatory Implications

Centrus is navigating a complex regulatory environment, particularly concerning the Import Ban Act and its impact on the TENEX Supply Contract. The company's ability to secure government waivers is paramount. Furthermore, its strategic initiatives in HALEU and LEU production are closely tied to U.S. government policy and funding, highlighting the importance of regulatory alignment.

What Investors Should Do

  1. Monitor DOE contract performance and funding
  2. Track developments regarding the Import Ban Act and waivers
  3. Assess progress in HALEU production scale-up

Key Dates

Glossary

LEU
Low-Enriched Uranium, a form of uranium used as fuel in most nuclear power reactors. (Centrus's primary product and revenue driver.)
HALEU
High-Assay Low-Enriched Uranium, a more enriched form of uranium required for advanced nuclear reactor designs. (A key strategic growth area for Centrus, with significant government backing.)
IDIQ
Indefinite Delivery, Indefinite Quantity contract. A type of contract that provides for an indeterminate quantity of services or supplies during a specified contract period. (The structure of new contracts awarded by the DOE for HALEU and LEU production, providing a framework for future work.)
Import Ban Act
Legislation that could restrict or ban the import of Russian enriched uranium into the United States. (A major regulatory risk impacting Centrus's ability to fulfill contracts and its competitive landscape.)
TENEX Supply Contract
An existing agreement with TENEX, a Russian entity, for the supply of enriched uranium. (Crucial for current operations but faces significant uncertainty due to import restrictions and geopolitical factors.)

Year-Over-Year Comparison

Centrus Energy Corp. has demonstrated significant top-line growth, with revenue increasing by 33.3% to $105.2 million for the three months ended September 30, 2025, compared to $78.9 million in the prior year, primarily driven by its LEU segment. Net income also saw a substantial rise to $15.8 million, or $0.90 per diluted share, from $10.1 million, or $0.58 per diluted share, indicating improved profitability. A key positive development is the redemption of the 8.25% Notes in March 2025, which will reduce future interest expenses. However, the company continues to face heightened risks related to geopolitical events and regulatory changes impacting its supply chain.

Filing Stats: 4,589 words · 18 min read · ~15 pages · Grade level 12 · Accepted 2025-11-06 07:00:46

Key Financial Figures

Filing Documents

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited): Consolidated Balance Sheets at September 30, 2025 and December 31, 2024 10 Consolidated Statements of Operations and Comprehensive Income for the Three and Nine Months Ended September 30, 2025 and 2024 11 Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 12 Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended September 30, 2025 and 2024 13

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 15 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 38 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 64 Item 4.

Controls and Procedures

Controls and Procedures 64

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 65 Item 1A.

Risk Factors

Risk Factors 65 Item 5. Other Information 67 Item 6. Exhibits 68

Signatures

Signatures 69 2 Glossary of Certain Terms and Abbreviations Centrus Energy Corp. and Related Entities ACO American Centrifuge Operating LLC, a subsidiary of Centrus Board Centrus Energy Corp.'s Board of Directors Centrus Centrus Energy Corp. Enrichment Corp. United States Enrichment Corporation, a subsidiary of Centrus Paducah GDP Paducah Gaseous Diffusion Plant, an enrichment plant in Paducah, Kentucky, formerly operated by Enrichment Corp. Piketon Production facility in Piketon, Ohio Portsmouth GDP Portsmouth Gaseous Diffusion Plant, an enrichment plant near Portsmouth, Ohio, formerly operated by Enrichment Corp. USEC-Government Enrichment Corp. prior to 1993, a wholly-owned government corporation prior to its privatization in July 1998 Other Terms and Abbreviations 0% Convertible Notes 0% Convertible Senior Notes, maturing August 2032 unless repurchased, redeemed or converted 2.25% Convertible Notes 2.25% Convertible Senior Notes, maturing November 2030 unless repurchased, redeemed or converted 2002 DOE-USEC Agreement June 17, 2002 agreement between Centrus (then known as USEC Inc.) and the DOE 5B Cylinders Storage cylinders for HALEU UF 6 produced by the cascade 8.25% Notes 8.25% Notes, originally maturing February 2027, redeemed in March 2025 American Centrifuge Advanced uranium enrichment gas centrifuge technology previously developed, based on the proven workable U.S. centrifuge technology developed by DOE in the mid-1980s and utilized in a demonstration facility in 2012-2013 American Centrifuge Plant Refers to a demonstration facility in Piketon, Ohio where USEC planned to install a lead cascade of centrifuge machines to demonstrate the American Centrifuge technology under the terms of the 2002 DOE-USEC Agreement ARDP DOE's Advanced Reactor Demonstration Program ATM At the Market Class A Common Stock Class A common stock, $0.10 par value per share Class B Common Stock Class B common stock, $0.10 par value per sha

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING INFORMATION This Quarterly Report on Form 10-Q of Centrus (the "Company," "we" or "us") contains "forward-looking statements" within the meaning of Section 21E of the Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "will", "should", "could", "would" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q and represent management's current views and assumptions with respect to future events and operational, economic and financial performance. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties and other factors, which may be beyond our control. The factors that could cause actual results to differ materially from the forward-looking statements made by us include those factors discussed herein, including those factors discussed in (a) Part I, Item 1. Financial Statements (Unaudited) : Note 12, Commitments and Contingencies , (b) Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations, (c) Part II, Item 1A. Risk Factors , and (d) other factors discussed in the Company's filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report. The Company does not undertake any obligation to publicly release any revision to its forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q unless required by law.

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing